Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Home - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 722239 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Printer Friendly
PDF Brochure
Send to Friend
Enquire before Buying
| More
ElectronicAdd to Basket



Japanese Pharma to 2008: Innovation and Expansion Will Counter the Western Threat
Datamonitor, Jan 2003, Pages: 383


  Description  
  Table of Contents  
    
    
    
   
 Enquire before Buying  
 Send to a Friend  

Introduction

Dominated by domestic companies in the past, the Japanese pharmaceutical market is evolving, as regulatory changes stimulate increased competition from western companies and government cost containment measures restrict market growth. The Japanese pharmaceutical companies must focus on building strong pipelines in order to drive both domestic and overseas growth.

Scope

Benchmarking of leading players across a range of strategic, portfolio and financial measures, supported by an interactive Excel-based comparator tool

Profiles 17 Japanese pharma companies, providing analysis of the company’s strategy, portfolio and pipeline and 6 year forecasts for key products

Evaluation of the strategic options available for Japanese pharmas to drive domestic and overseas expansion

Assessment of the strategies used by western big pharma to increase penetration of the Japanese market

Report Highlights

Japanese companies must focus on R&D due to the weaknesses of their mature portfolios. In 2002, 71.3% of the leading Japanese companies revenues came from drugs that are more than 10 years old

Overseas companies must consider their therapeutic focus and marketing capabilities to choose the best Japanese expansion strategy. Although recent changes have made it possible, and indeed far easier for western companies to launch their own products in Japan, many still choose to either out-license products or to co-promote/co-market them

Fujisawa is forecast to be the best performing Japanese company to 2008, reaping the rewards of its extensive alliance network, which included 20 new corporate agreements from January 2000 to October 2003. Other companies should look to follow suit if they are to successfully drive future growth

Reasons to Purchase

Benchmark your performance against the leading Japanese pharmas

Identify the best product sourcing strategy for your company’s position

Optimize your Japanese market growth strategy through detailed knowledge of the performance of the Japanese pharmas, and local operating conditions




Customers who bought this item also bought

Br. Holdings Corporation

Br Malls Participacoes Sa

The 2009 Import and Export Market for Butadiene Rubber (BR) in Japan

The World Market for Butadiene Rubber (BR): A 2009 Global Trade Perspective

The 2009 Import and Export Market for Butadiene Rubber (BR) in Iran

The 2009 Import and Export Market for Butadiene Rubber (BR) in Bulgaria

The 2009 Import and Export Market for Butadiene Rubber (BR) in Colombia

The 2009 Import and Export Market for Butadiene Rubber (BR) in Estonia

The 2009 Import and Export Market for Butadiene Rubber (BR) in Slovakia

The 2009 Import and Export Market for Butadiene Rubber (BR) in Turkey

The 2009 Import and Export Market for Butadiene Rubber (BR) in India

The 2009 Import and Export Market for Butadiene Rubber (BR) in Belarus



Top of page


   All rights reserved. � Copyright 2009 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster


Research and Markets RSS Feeds